Characterization of the metabolism of perinecrotic cells in solid tumors by enzyme histochemistry.
Hypoxic tumor cells resist most therapies and cause tumor regrowth when their environment improves. Identifying the adaptation strategies to hypoxia would help develop better tailored cancer therapies. Ehrlich carcinomas implanted on mice were analyzed histochemically for the following enzyme activities: lactate, succinate and glucose-6-phosphate dehydrogenases, dihydrofolate reductase, purine nucleoside phosphorylase, xanthine oxidoreductase, and acid phosphatase. With the exception of xanthine oxidoreductase, which was not active in tumor cells, and of succinate dehydrogenase the activity of which was not significatively altered, all other activities were much higher in perinecrotic cells with respect to cells close to blood vessels. These data suggest the integration of metabolic paths allowing purine and lipid biosyntheses. Degradation products from the necrosis are presumed to be employed as surrogates of blood-borne nutritive substances by cells distant from the vascularization.
Freitas
I
I
Department of Animal Biology, University of Pavia, Italy.
Bono
B
B
Bertone
V
V
Griffini
P
P
Baronzio
G F
GF
Bonandrini
L
L
Gerzeli
G
G
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology* / Q000473:pathology; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D051379:Mice; D009336:Necrosis; D011683:Purine-Nucleoside Phosphorylase / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism
D007770:L-Lactate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D013762:Tetrahydrofolate Dehydrogenase; D011683:Purine-Nucleoside Phosphorylase; D000135:Acid Phosphatase